Moreover, we found its expression is positively correlated with GBM patients’ poor prognosis, and PRRX2 overexpression could promote GSCs viability, proliferation, and neurospheres formation via inhibiting ferroptosis. This evidence concerns the gene PRRX2 and glioblastoma.